Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Grant or award President and CEO acquired 111,000 shares (grant or award)
  2. 8-K Event Other events
  3. 4 Open-market sale Chief Technology Officer sold 2,627 shares at $26.24 ($68,925)
  4. 8-K Event Other events
  5. 4 Option exercise EVP, Research & CSO acquired 9,000 shares (option exercise)
  6. 4 Grant or award Chief Business Officer, Global acquired 90,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-K Report Annual Report
  10. 4 Grant or award Chief Technology Officer acquired 53,500 shares (grant or award)
  11. 4 Grant or award Chief Medical Officer acquired 67,000 shares (grant or award)
  12. 4 Grant or award Chief Administrative Officer acquired 20,000 shares (grant or award)
  13. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $30.00 ($41,250)
  14. 4 Grant or award CFO acquired 35,000 shares (grant or award)
  15. 8-K Event Results of operations · Regulation FD disclosure
  16. 4 Open-market sale EVP, Research & CSO sold 2,293 shares at $31.93 ($73,218)
  17. 4 Open-market sale President and CEO sold 27,750 shares at an average $31.11 ($863,378)
  18. 4 Open-market sale Chief Administrative Officer sold 1,942 shares at $31.93 ($62,010)
  19. 4 Open-market sale CFO sold 2,393 shares at $31.93 ($76,411)
  20. 4 Open-market sale Chief Medical Officer sold 8,009 shares at an average $31.69 ($253,780)

Page 23 of 41 · 806 filings